Literature DB >> 18849560

Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Theresa Mayes1, Michele Gottschlich, Jane Khoury, Petra Warner, Richard Kagan.   

Abstract

INTRODUCTION: The primary purpose of this study was to compare the measured resting energy requirements (MREE) of children with Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) with that of children with burns of similar size. A secondary goal was to develop a predictive equation useful in estimating the energy of children with SJS/TEN.
METHODS: This retrospective study included 30 patients admitted to our pediatric burn unit between 12/91 and 03/06. All patients were admitted within 10 days of injury and had at least 1 metabolic cart measurement. Fifteen patients with SJS/TEN comprised group 1. Group 2 consisted of 15 burn patients matched for total wound size, age, preinjury weight, and gender. Caloric intake and discharge weight (percent of preburn weight) were recorded.
RESULTS: The energy needs of the SJS/TEN group were 22% less than the burn group. Correlation between MRE x 1.3 and caloric intake was 0.89 for the SJS/TEN group and 0.92 for the burn group (P < .0001). Both the SJS/TEN and burn groups were managed by nutrition goals based on the MREE x 1.3, and patients were 95.1% +/- 6.3% and 98.9% +/- 6% of preinjury weight at discharge, respectively, in each group. An equation for the estimation of energy requirements in pediatric SJS/TEN patients was statistically generated: (24.6 x weight in kg) + (% wound x 4.1) + 940.
CONCLUSION: The energy requirement in pediatric SJS/TEN patients is less than that following burn injury. The application of a 30% factor to MREE is supported in SJS/TEN and thermal injury.

Entities:  

Mesh:

Year:  2008        PMID: 18849560     DOI: 10.1177/0884533608323434

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  9 in total

Review 1.  Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Authors:  Michele L Ramien; Danny Mansour; Neil H Shear
Journal:  Paediatr Drugs       Date:  2022-06-09       Impact factor: 3.022

Review 2.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22

3.  Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer.

Authors:  Mozaffar Aznab; Mansour Khazaei
Journal:  Iran J Cancer Prev       Date:  2016-06-13

4.  Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Lucia Liotti; Silvia Caimmi; Paolo Bottau; Roberto Bernardini; Fabio Cardinale; Francesca Saretta; Francesca Mori; Giuseppe Crisafulli; Fabrizio Franceschini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-29

5.  Resting Energy Expenditure Prediction Equations in the Pediatric Population: A Systematic Review.

Authors:  Jimena Fuentes-Servín; Azalia Avila-Nava; Luis E González-Salazar; Oscar A Pérez-González; María Del Carmen Servín-Rodas; Aurora E Serralde-Zuñiga; Isabel Medina-Vera; Martha Guevara-Cruz
Journal:  Front Pediatr       Date:  2021-12-06       Impact factor: 3.418

Review 6.  A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis.

Authors:  Piyu Parth Naik
Journal:  Scars Burn Heal       Date:  2022-09-13

7.  A 7-year-old boy with toxic epidermal necrolysis, heart failure, and sepsis treated with the guidance of invasive hemodynamic monitoring: A case report.

Authors:  Amir Saeed; Nima Mehdizadegan
Journal:  Clin Case Rep       Date:  2021-07-06

Review 8.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.

Authors:  Jeremy A Schneider; Philip R Cohen
Journal:  Adv Ther       Date:  2017-04-24       Impact factor: 3.845

9.  Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.

Authors:  Lu Yang; Yan-Hong Shou; Feng Li; Xiao-Hua Zhu; Yong-Sheng Yang; Jin-Hua Xu
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.